- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Growth Potential Companies
Global Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Mar 23, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
520 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
IPH | €2.17 | 0.5% | -16.0% | €175.0m | €6.32 | PS2.8x | E16.4% | n/a | ||
BIOT | kr173.60 | -1.4% | 38.7% | kr14.0b | kr186.67 | PE56.9x | E18.0% | 0.9% | ||
CTLT | US$55.79 | -0.8% | -13.2% | US$10.1b | US$63.50 | PS2.5x | E94.0% | n/a | ||
PFE | US$27.36 | -2.1% | -32.3% | US$154.9b | US$32.70 | PE72.6x | E20.6% | 6.1% | ||
HBIO | US$4.17 | 3.0% | 34.5% | US$181.0m | US$7.00 | PS1.6x | E98.9% | n/a | ||
A170900 | ₩74,000.00 | -0.5% | 39.3% | ₩627.6b | ₩80,957.52 | PE56.4x | E47.5% | 0.9% | ||
2675 | CN¥15.50 | -1.7% | -2.9% | CN¥12.8b | CN¥20.30 | PE48.6x | E30.2% | 1.0% | ||
300841 | CN¥59.76 | -10.4% | -37.6% | CN¥8.0b | CN¥96.33 | PE16.5x | E21.8% | 0.8% | ||
INDOCO | ₹334.80 | 2.7% | 2.2% | ₹30.9b | ₹395.20 | PE30.4x | E32.7% | 0.7% | ||
STAR | ₹777.15 | -1.4% | 182.9% | ₹71.4b | ₹830.50 | PS1.8x | E112.8% | 0.2% | ||
301047 | CN¥73.03 | -2.0% | -29.2% | CN¥9.4b | CN¥102.50 | PE40.6x | E20.3% | 2.7% | ||
GLENMARK | ₹951.00 | 2.6% | 123.4% | ₹268.4b | ₹923.00 | PS2x | E58.8% | 0.3% | ||
4577 | JP¥2,277.00 | 2.3% | 3.6% | JP¥35.6b | JP¥3,155.00 | PE10.5x | E11.3% | 2.6% | ||
2399 | CN¥8.85 | 1.4% | -37.1% | CN¥11.6b | CN¥7.10 | PE38.3x | E29.6% | 1.1% | ||
600436 | CN¥233.91 | 0.1% | -16.8% | CN¥141.1b | CN¥295.86 | PE50.7x | E20.8% | 0.5% | ||
A006280 | ₩124,400.00 | 4.1% | 6.6% | ₩1.4t | ₩145,000.00 | PE764.3x | E108.5% | 1.2% | ||
PNT | US$12.50 | 0.2% | 75.1% | US$1.3b | US$12.50 | PE13.8x | E9.2% | n/a | ||
KZA | AU$0.08 | -27.3% | -17.5% | AU$18.9m | n/a | PS34068.4x | E49.6% | n/a | ||
LIPUM | kr6.84 | 2.7% | -44.4% | kr63.7m | kr20.00 | PB13.9x | E74.9% | n/a | ||
NIOX | UK£0.66 | 0.6% | 44.1% | UK£279.4m | n/a | PE34.5x | E18.4% | n/a | ||
MDXG | US$8.04 | 2.0% | 137.2% | US$1.2b | US$12.52 | PE21.2x | E15.7% | n/a | ||
NLSP | US$0.18 | -41.7% | -85.7% | US$6.5m | n/a | PE-0.4x | E55.6% | n/a | ||
FTRE | US$38.93 | -0.9% | n/a | US$3.5b | US$39.07 | PS1.1x | E45.3% | n/a | ||
ORGO | US$2.61 | -8.4% | 38.1% | US$344.4m | US$4.83 | PE69.7x | E46.4% | n/a |